On Saturday, CVS Health Corporation announced that they were pulling Zantac and generic type tablets from their shelves. Following suit, Walgreen said they will stop selling the popular heartburn medecine after the Food and Drug Administration found traces of a known carcinogen in some products.
Read more on this story from NEWS15,
https://kadn.com/walgreens-cvs-suspend-sales-of-zantac-brand-due-to-contaminant-fears/